• RNA Exon Editing with Ascidian Therapeutics' Drs. Robert Bell and Michael Ehlers - The Molecular Therapy Podcast

  • Jan 7 2025
  • Length: 38 mins
  • Podcast

RNA Exon Editing with Ascidian Therapeutics' Drs. Robert Bell and Michael Ehlers - The Molecular Therapy Podcast

Listen for free

View show details

  • Summary

  • Join Dr. Paloma Giangrande, Editor-in-Chief of Molecular Therapy Nucleic Acids, as she discusses RNA exon editing with Ascidian Therapeutics' leadership: CSO Dr. Robert Bell and CEO Dr. Michael Ehlers. Their conversation explores Dr. Bell's recent MTNA publication "RNA Exon Editing: Splicing the Way to Treat Human Diseases."

    Last Call: Submit your abstracts for ASGCT's 2025 Annual Meeting in New Orleans by January 31st, 11:59 PM ET. Present at cell and gene therapy's premier event and get published in Molecular Therapy. Details at annualmeeting.asgct.org/abstracts.

    In This Episode

    Paloma Giangrande, PhD
    Editor-in-Chief, Molecular Therapy Nucleic Acids and Chief Technology Officer at Eleven Therapeutics

    Robert Bell, PhD
    Chief Scientific Officer at Ascidian Therapeutics

    Michael Ehlers, MD, PhD
    President and Chief Executive Officer at Ascidian Therapeutics

    'Electric Dreams' by Scott Buckley - released under CC-BY 4.0.
    www.scottbuckley.com.au

    Show your support for ASGCT!: https://asgct.org/membership/donate

    See omnystudio.com/listener for privacy information.
    Show more Show less
Show more Show less

What listeners say about RNA Exon Editing with Ascidian Therapeutics' Drs. Robert Bell and Michael Ehlers - The Molecular Therapy Podcast

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available